Ponikowski P, Hańczycowa H, Sebzda T, Jurga M, Spring A, Rotter A, Jordanek P
Zakładu Podstawowej Opieki Zdrowotnej Ak. Med., Wrocławiu.
Wiad Lek. 1993 Apr;46(7-8):250-4.
The effect of enalapril and terazosin on serum lipid profile was investigated in 36 patients with primary hypertension and hypercholesterolemia (total cholesterol 5.2 mmol l). 6- and 12-week monotherapy with these drugs did not produce any unfavourable changes in: total cholesterol, LDL- and HDL-cholesterol, triglycerides, apolipoproteins A1 and B as well as in serum lipids. Enalapril and terazosin seem to be very useful as a first step monotherapy especially in patients with hypertension and lipid disturbances.
在36例原发性高血压合并高胆固醇血症（总胆固醇≥5.2 mmol/L）患者中研究了依那普利和特拉唑嗪对血脂谱的影响。使用这些药物进行6周和12周的单药治疗，在总胆固醇、低密度脂蛋白胆固醇和高密度脂蛋白胆固醇、甘油三酯、载脂蛋白A1和B以及血脂方面均未产生任何不利变化。依那普利和特拉唑嗪作为初始单药治疗似乎非常有用，尤其是对于患有高血压和血脂紊乱的患者。
